178 related articles for article (PubMed ID: 24887452)
1. Poor responses to interferon-beta treatment in patients with neuromyelitis optica and multiple sclerosis with long spinal cord lesions.
Wang KC; Lin KH; Lee TC; Lee CL; Chen SY; Chen SJ; Chin LT; Tsai CP
PLoS One; 2014; 9(6):e98192. PubMed ID: 24887452
[TBL] [Abstract][Full Text] [Related]
2. Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination.
Warabi Y; Matsumoto Y; Hayashi H
J Neurol Sci; 2007 Jan; 252(1):57-61. PubMed ID: 17125797
[TBL] [Abstract][Full Text] [Related]
3. Interferon-β1b increases Th2 response in neuromyelitis optica.
Nakajima H; Hosokawa T; Doi Y; Ikemoto T; Ishida S; Kimura F; Hanafusa T
Int J Mol Sci; 2012 Sep; 13(10):12213-23. PubMed ID: 23202893
[TBL] [Abstract][Full Text] [Related]
4. Antibodies against interferon-beta in neuromyelitis optica patients.
Asgari N; Kyvik KO; Steenstrup T; Stenager E; Lillevang ST
J Neurol Sci; 2014 Apr; 339(1-2):52-6. PubMed ID: 24477087
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of interferon β-1b in Japanese patients with optic-spinal multiple sclerosis.
Shimizu Y; Fujihara K; Kubo S; Takahashi T; Misu T; Nakashima I; Yokoyama K; Itoyama Y; Uchiyama S
Tohoku J Exp Med; 2011 Mar; 223(3):211-4. PubMed ID: 21403431
[TBL] [Abstract][Full Text] [Related]
6. Early and extensive spinal white matter involvement in neuromyelitis optica.
Hayashida S; Masaki K; Yonekawa T; Suzuki SO; Hiwatashi A; Matsushita T; Watanabe M; Yamasaki R; Suenaga T; Iwaki T; Murai H; Kira JI
Brain Pathol; 2017 May; 27(3):249-265. PubMed ID: 27082714
[TBL] [Abstract][Full Text] [Related]
7. Characteristic linear lesions and longitudinally extensive spinal cord lesions in Chinese patients with neuromyelitis optica.
Lu Z; Qiu W; Zou Y; Lv K; Long Y; You W; Zheng X; Hu X
J Neurol Sci; 2010 Jun; 293(1-2):92-6. PubMed ID: 20346462
[TBL] [Abstract][Full Text] [Related]
8. [The correlation factor analysis for conversion of clinically isolated syndrome to multiple sclerosis and neuromyelitis optica].
Bi CF; Qian HR; Peng LJ; Mao LL; Huang X; Xia DY; Lei X; Qi XK
Zhonghua Nei Ke Za Zhi; 2016 Jun; 55(6):460-5. PubMed ID: 27256609
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of a woman with relapsing neuromyelitis optica by interferon beta.
Xu Y; Zhang Y; Ye J; Peng B; Wang JM; Cui LY
Neurol Sci; 2012 Aug; 33(4):911-3. PubMed ID: 22120187
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.
Matsuoka T; Matsushita T; Kawano Y; Osoegawa M; Ochi H; Ishizu T; Minohara M; Kikuchi H; Mihara F; Ohyagi Y; Kira J
Brain; 2007 May; 130(Pt 5):1206-23. PubMed ID: 17439988
[TBL] [Abstract][Full Text] [Related]
11. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
[TBL] [Abstract][Full Text] [Related]
12. Different patterns of longitudinal brain and spinal cord changes and their associations with disability progression in NMO and MS.
Liu Y; Duan Y; Huang J; Ren Z; Liu Z; Dong H; Weiler F; Hahn HK; Shi FD; Butzkueven H; Barkhof F; Li K
Eur Radiol; 2018 Jan; 28(1):96-103. PubMed ID: 28667482
[TBL] [Abstract][Full Text] [Related]
13. Revised diagnostic criteria for neuromyelitis optica.
Wingerchuk DM; Lennon VA; Pittock SJ; Lucchinetti CF; Weinshenker BG
Neurology; 2006 May; 66(10):1485-9. PubMed ID: 16717206
[TBL] [Abstract][Full Text] [Related]
14. Interferon-beta(1b) treatment in neuromyelitis optica.
Tanaka M; Tanaka K; Komori M
Eur Neurol; 2009; 62(3):167-70. PubMed ID: 19590215
[TBL] [Abstract][Full Text] [Related]
15. "Bright spotty lesions" on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis.
Yonezu T; Ito S; Mori M; Ogawa Y; Makino T; Uzawa A; Kuwabara S
Mult Scler; 2014 Mar; 20(3):331-7. PubMed ID: 23828869
[TBL] [Abstract][Full Text] [Related]
16. Interferon-β-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab.
Harmel J; Ringelstein M; Ingwersen J; Mathys C; Goebels N; Hartung HP; Jarius S; Aktas O
BMC Neurol; 2014 Dec; 14():247. PubMed ID: 25516429
[TBL] [Abstract][Full Text] [Related]
17. Brain abnormalities in neuromyelitis optica.
Pittock SJ; Lennon VA; Krecke K; Wingerchuk DM; Lucchinetti CF; Weinshenker BG
Arch Neurol; 2006 Mar; 63(3):390-6. PubMed ID: 16533966
[TBL] [Abstract][Full Text] [Related]
18. Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging.
Pekcevik Y; Mitchell CH; Mealy MA; Orman G; Lee IH; Newsome SD; Thompson CB; Pardo CA; Calabresi PA; Levy M; Izbudak I
Mult Scler; 2016 Mar; 22(3):302-11. PubMed ID: 26209588
[TBL] [Abstract][Full Text] [Related]
19. Analysis of brain and spinal cord lesions to occult brain damage in seropositive and seronegative neuromyelitis optica.
Sun J; Sun X; Zhang N; Wang Q; Cai H; Qi Y; Li T; Qin W; Yu C
Eur J Radiol; 2017 Sep; 94():25-30. PubMed ID: 28941756
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of long spinal cord lesions and anti-aquaporin 4 antibodies in neuromyelitis optica patients in Taiwan.
Wang KC; Tsai CP; Lee CL; Chen SY; Chen SJ
Eur Neurol; 2011; 65(2):99-104. PubMed ID: 21273778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
